CClinicalTrials.gg
TerminatedNCT05591794Updated Feb 10, 2026

Effects of Diet Versus Diet Plus Aerobic and Resistant Exercise Program in Overweight Women

An interventional study of Aerobic and resistance exercises and Diet program in Overweight and Exercise, sponsored by Bezmialem Vakif University. Terminated at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment

Why this study was terminated
The study was halted prematurely following the departure of two researchers, resulting in insufficient research capacity to continue the study.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Adult women aged 18-50 years and overweight (preobese) with a BMI of 25-30 kg/m2 will be included in the study. Participants will participate in an eight-week diet and diet plus aerobic and resistance exercise program. Patients will be referred from the Nutrition and Diet Polyclinic of Bezmialem Vakıf University to this study, which will be conducted to investigate the effects of exercise program on postural control, musculoskeletal system disorders, functional capacity, and sleep.

Read the detailed description

Subjects who accepted to participate in the study will be randomized and divided into two groups as study and control groups. A computer-based randomization program (random.org) will be used to determine the cases to be assigned to the study and control groups. 2 numbers consisting of 12 numbers will be determined by random selection from the numbers between 1 and 24. The first of these number sequences will be considered as the study group and the second as the control group. Each patient included in the study will be asked to draw one of the sealed envelopes in which the numbers 1 to 24 are written. The case will be assigned to the study or control group according to the number sequence in which the drawn number is included. While the women in the study group are expected to perform regular walking with a diet for eight weeks and a 3-day aerobic and resistance exercise program per week, the subjects in the control group will be followed up with diet and regular walking. Initially, participants will be educated on healthy eating habits through one-on-one dietitian consultation. A personalized calorie-restricting nutrition program will be given. According to this program, the daily energy intake of the individual will be reduced to provide 0.5-1.0 kg of body weight loss per week.

02

Conditions studied

  • Overweight
  • Exercise

Keywords

  • Overweight
  • Aerobic and resistance exercise
  • Postural control
  • Musculoskeletal disorders
  • Functional capacity
  • Sleep
03

In context

Overweight

3,670 studies on the registry are indexed under Overweight; 849 are open to participants now.

This study's enrollment of 24 is below the median of 73 across 3,175 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 345 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI between 25-29.9kg/m2
  • Being between the ages of 18-50
  • Agreeing to participate voluntarily in the study

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Presence of systemic disease that will prevent participation in an aerobic exercise program
  • Presence of conditions such as pain or surgery that will prevent participation in an aerobic exercise program
  • Participating in a regular exercise program within the last 1 year
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Study group

    The women in the study group will be asked to walk for 30 minutes/5 days or 50 minutes/3 days a week while performing a diet program for eight weeks and aerobic and resistance exercise program 3 days a week.

    Other: Aerobic and resistance exercises · Dietary Supplement: Diet program · Other: Regular walking program

  • Active comparator
    Control group

    The women in the control group will be asked to walk for 30 minutes/5 days or 50 minutes/3 days a week while performing a diet program.

    Dietary Supplement: Diet program · Other: Regular walking program

Interventions

  • OtherAerobic and resistance exercises

    Participants in the study group will be given an aerobic exercise program on the treadmill for 8 weeks, 2 days a week, 20 minutes at a rate of 60-80% of the target heart rate. Participants will work on the treadmill for 20 minutes at 60-70% of the target heart rate for the first four weeks, and at 70-80% of the target heart rate for the last four weeks. Resistance exercises will consist of exercises that will work large muscle groups with rubber bands. According to Borg, the resistance exercises to be applied will be three sets of 10 repetitions for each movement at an RPE of 11-12 during the first four weeks, and 3 sets of 15 repetitions at the same RPE for the last four weeks, 2 times a week for 20 minutes.

  • Dietary supplementDiet program

    Initially, participants will be educated on healthy eating habits through one-on-one dietitian consultation. A personalized calorie-restricting diet will be given. According to this program, the daily energy intake of the individual will be reduced to provide 0.5-1.0 kg of body weight loss per week.

  • OtherRegular walking program

    Regular walking will be recommended as 30 minutes/5 days or 50 minutes/3 days per week.

06

What researchers measure

Primary outcomes

  1. Evaluation of postural control by Biodex Balance System

    Postural control evaluation will be performed with "Biodex Balance System®" (Biodex Medical Systems, Shirley, New York, USA) which is a valid and reliable equipment. Three tests will be performed with the device: postural stability test, stability limits test, and modified clinical test of sensory integration of balance. During the evaluation, three measurements of 20 seconds, 10 seconds intervals between each measurement, will be performed in all tests. Higher control over balance is indicated by a lower score of overall, anterior/posterior, and medial/lateral stability index in the PS test. However, a higher score indicates a lower level of postural control in stability limits and modified clinical test of sensory integration of balance tests.

    Time frame: Change between baseline and 8-week scores of Biodex Balance System.

Secondary outcomes

  1. Evaluation of musculoskeletal by Extended Nordic Musculoskeletal Questionnaire

    The Extended Nordic Musculoskeletal Questionnaire is a reliable instrument that measures the prevalence, severity and impact of musculoskeletal symptoms.

    Time frame: Change between baseline and 8-week scores of Extended Nordic Musculoskeletal Questionnaire.

  2. Evaluation of functional capacity by 6 minute walk test

    The 6 Minute Walk Test is a sub-maximal exercise test used to assess functional capacity and endurance.

    Time frame: Change between baseline and 8-week scores of 6 Minute Walk Test.

  3. Evaluation of sleep quality by Pittsburgh Sleep Quality Index

    The Pittsburgh Sleep Quality Index is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval.

    Time frame: Change between baseline and 8-week scores of Pittsburgh Sleep Quality Index.

07

Study locations

1 site
  • Bezmialem Vakif University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05591794
Lead sponsor
Bezmialem Vakif University
Responsible party
Deniz Tuncer (Assistant professor, Bezmialem Vakif University) — Principal investigator
First posted
Oct 24, 2022
Start date
Sep 1, 2022
Primary completion
Oct 1, 2024
Completion
Dec 1, 2024
Last update
Feb 10, 2026

Study contacts

Deniz Tuncer, PhD, PT
principal investigator · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion